| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 682996 | Null | 0.035202825328704 | 0.49687324 |
| NSC 685285 | Null | 0.035202825328704 | 0.0070166503 |
| NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.035202825328704 | 0.35711652 |
| NSC 716503 | Null | 0.035202825328704 | 0.12086525 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.035202825328704 | 0.4085822 |
| NSC 720320 | 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole | 0.035202825328704 | -0.039858354 |
| NSC 725098 | Null | 0.035202825328704 | 0.34030403 |
| NSC 726217 | Combretastatin A4-analogue | 0.035202825328704 | 0.24612937 |
| NSC 731704 | 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. | 0.0352028253287042 | 0.34916022 |
| NSC 732205 | Null | 0.0352028253287042 | 0.64481495 |